Literature DB >> 23689371

Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion.

Lei-Lei Jiang1, Mei-Xia Che, Jian Zhao, Chen-Jie Zhou, Mu-Yun Xie, Hai-Yin Li, Jian-Hua He, Hong-Yu Hu.   

Abstract

TDP-43 (TAR DNA-binding protein of 43 kDa) is a major deposited protein in amyotrophic lateral sclerosis and frontotemporal dementia with ubiquitin. A great number of genetic mutations identified in the flexible C-terminal region are associated with disease pathologies. We investigated the molecular determinants of TDP-43 aggregation and its underlying mechanisms. We identified a hydrophobic patch (residues 318-343) as the amyloidogenic core essential for TDP-43 aggregation. Biophysical studies demonstrated that the homologous peptide formed a helix-turn-helix structure in solution, whereas it underwent structural transformation from an α-helix to a β-sheet during aggregation. Mutation or deletion of this core region significantly reduced the aggregation and cytoplasmic inclusions of full-length TDP-43 (or TDP-35 fragment) in cells. Thus, structural transformation of the amyloidogenic core initiates the aggregation and cytoplasmic inclusion formation of TDP-43. This particular core region provides a potential therapeutic target to design small-molecule compounds for mitigating TDP-43 proteinopathies.

Entities:  

Keywords:  Aggregation; Amyloid; Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Circular Dichroism (CD); Fluorescence; Hydrophobic Patch; Inclusion Formation; NMR; Structural Transformation; TDP-43

Mesh:

Substances:

Year:  2013        PMID: 23689371      PMCID: PMC3707662          DOI: 10.1074/jbc.M113.463828

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.

Authors:  Sandrine Da Cruz; Don W Cleveland
Journal:  Curr Opin Neurobiol       Date:  2011-08-02       Impact factor: 6.627

2.  Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.

Authors:  Akash Saini; Virander Singh Chauhan
Journal:  Chembiochem       Date:  2011-09-08       Impact factor: 3.164

3.  An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity.

Authors:  Weirui Guo; Yanbo Chen; Xiaohong Zhou; Amar Kar; Payal Ray; Xiaoping Chen; Elizabeth J Rao; Mengxue Yang; Haihong Ye; Li Zhu; Jianghong Liu; Meng Xu; Yanlian Yang; Chen Wang; David Zhang; Eileen H Bigio; Marsel Mesulam; Yan Shen; Qi Xu; Kazuo Fushimi; Jane Y Wu
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

Review 4.  Implications of the prion-related Q/N domains in TDP-43 and FUS.

Authors:  Maria Udan; Robert H Baloh
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

5.  Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.

Authors:  Mei-Xia Che; Ya-Jun Jiang; Yuan-Yuan Xie; Lei-Lei Jiang; Hong-Yu Hu
Journal:  FASEB J       Date:  2011-03-30       Impact factor: 5.191

6.  A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport.

Authors:  G Scott Pesiridis; Kalyan Tripathy; Selçuk Tanik; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

7.  Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.

Authors:  Mauricio Budini; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Valentina Romano; Laura De Conti; Francisco E Baralle
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

8.  Caenorhabditis elegans RNA-processing protein TDP-1 regulates protein homeostasis and life span.

Authors:  Tao Zhang; Ho-Yon Hwang; Haiping Hao; Conover Talbot; Jiou Wang
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

9.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; Stephanie C Huelga; Jacqueline Moran; Tiffany Y Liang; Shuo-Chien Ling; Eveline Sun; Edward Wancewicz; Curt Mazur; Holly Kordasiewicz; Yalda Sedaghat; John Paul Donohue; Lily Shiue; C Frank Bennett; Gene W Yeo; Don W Cleveland
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

10.  Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes.

Authors:  Chantelle F Sephton; Can Cenik; Alper Kucukural; Eric B Dammer; Basar Cenik; Yuhong Han; Colleen M Dewey; Frederick P Roth; Joachim Herz; Junmin Peng; Melissa J Moore; Gang Yu
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

View more
  53 in total

1.  The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.

Authors:  W Michael Babinchak; Raza Haider; Benjamin K Dumm; Prottusha Sarkar; Krystyna Surewicz; Jin-Kyu Choi; Witold K Surewicz
Journal:  J Biol Chem       Date:  2019-02-27       Impact factor: 5.157

2.  Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.

Authors:  Patricia F Kao; Yun-Ru Chen; Xiao-Bo Liu; Charles DeCarli; William W Seeley; Lee-Way Jin
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

3.  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.

Authors:  Li Zhu; Meng Xu; Mengxue Yang; Yanlian Yang; Yang Li; Jianwen Deng; Linhao Ruan; Jianghong Liu; Sidan Du; Xuehui Liu; Wei Feng; Kazuo Fushimi; Eileen H Bigio; Marsel Mesulam; Chen Wang; Jane Y Wu
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

Review 4.  Biomolecular Phase Separation: From Molecular Driving Forces to Macroscopic Properties.

Authors:  Gregory L Dignon; Robert B Best; Jeetain Mittal
Journal:  Annu Rev Phys Chem       Date:  2020-04-20       Impact factor: 12.703

5.  Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.

Authors:  Anukool A Bhopatkar; Vladimir N Uversky; Vijayaraghavan Rangachari
Journal:  J Biol Chem       Date:  2020-01-06       Impact factor: 5.157

6.  Elucidation of the Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation.

Authors:  Thanh D Do; Ali Chamas; Xueyun Zheng; Aaron Barnes; Dayna Chang; Tjitske Veldstra; Harmeet Takhar; Nicolette Dressler; Benjamin Trapp; Kylie Miller; Audrene McMahon; Stephen C Meredith; Joan-Emma Shea; Kristi Lazar Cantrell; Michael T Bowers
Journal:  Biochemistry       Date:  2015-06-24       Impact factor: 3.162

7.  Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.

Authors:  Rachel L French; Zachary R Grese; Himani Aligireddy; Dhruva D Dhavale; Ashley N Reeb; Niraja Kedia; Paul T Kotzbauer; Jan Bieschke; Yuna M Ayala
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

8.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

9.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

10.  Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils.

Authors:  Shotaro Shimonaka; Takashi Nonaka; Genjiro Suzuki; Shin-Ichi Hisanaga; Masato Hasegawa
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.